"interview" blog posts
Reducing the burden of TB in the world’s most in need communities with long-acting injectables
Ketho Angami is a member of the Global TB Community Advisory Board and Long-Acting Technologies Community Advisory Board. In 2016 he received the National Leadership AIDS Award in India, and also the Nagaland State Governor’s award in 2021. Ketho has been engaged in the field of community led advocacy for more than 15 years, working actively in the field of Tuberculosis, HIV and Viral Hepatitis by holding governments accountable for preventable deaths from infectious diseases. He has been engaged with the grassroots population and generating community demands for quality of service on a human rights-based approach.
Posted on: 24 March 2022
Investing in TB prevention strategies with Long-Acting injectables
Susan Swindells is Professor of Internal Medicine in the Section of Infectious Diseases at the University of Nebraska Medical Center, USA. She is a contributing investigator on TB clinical development for the LONGEVITY project. A native of England, Dr. Swindells earned her medical degree from University College London in 1977, with postgraduate training in England and at the University of Washington in Seattle. A clinician and active researcher, Dr. Swindells has many years’ experience in HIV-related translational and clinical research, with a special interest in tuberculosis co-infection.
Posted on: 24 March 2022
Living with TB: My Experience
Monica was raised in a small town called Kohima in North East India. In 2015 she was diagnosed with TB for which she was treated for more than two years. Monica experienced a difficult treatment regimen which included daily injections for nine months and oral medication throughout the duration of her illness. Monica experienced many problems when living with TB including stigma and many difficult side-effects.
Posted on: 24 March 2022